Awarded contract

NP48925b Hereditary Angioedema Branded Medicines (Berinert)

Details

Supplier(s)
CSL Behring
Value
£4,733,292
Topic
Pharmaceutical products
Published
4 April 2025

Tender description

Supply of C1-esterase inhibitor human powder and solvent for solution for injection vials (various strengths) (Berinert®) to NHS Scotland. Lot 1: The Framework Agreement is for the supply of hereditary angioedema (HAE) branded medicines to NHS Scotland. The Framework Agreement has been awarded as a single supplier framework agreement to one (1) Framework Participant.

Timeline

  1. Completed: Award published4 April 2025
    Current notice
  2. Completed: Award date4 April 2025

About the buyer

NHS National Services Scotland is a national healthcare body serving NHS Scotland, and its National Procurement arm is Scotland's largest procurement organisation. Suppliers apply for those tenders to get onto a national framework. The National Distribution Service then delivers stock to hospital wards and community centres across NHS Scotland.

Over the past 5 years, most of NHS National Services Scotland's contract awards have been in medical equipment and pharmaceuticals, IT services and transport equipment.

AI insights

  • Is there a preferred supplier?
  • What are the buyers pain points?
  • What has the buyer previously procured?
  • What are the key requirements?
Sign-up to enrich

Decision makers

Connect with the people behind this procurement.

Contact nameJob titlePhone numberWork email
Head of Procurement+44 •••• ••••••
Commercial Director+44 •••• ••••••
Procurement Manager+44 •••• ••••••
Category Lead+44 •••• ••••••
Senior Buyer+44 •••• ••••••
Contracts Manager+44 •••• ••••••

15 similar open tenders

See more open tenders related to Pharmaceutical products.

Explore all open tenders

Finding public sector work shouldn't be hard

Make your next tender search effortless with Stotles. Set up alerts, find decision maker contacts and never miss a good-fit opportunity again.